| Literature DB >> 35388098 |
Rina Das1, Parag Palit1, Md Ahshanul Haque1, Mustafa Mahfuz1, A S G Faruque2, Tahmeed Ahmed1.
Abstract
There is a lack of information highlighting the possible association between the genomic subtypes of enteropathogenic Escherichia coli (EPEC) on environmental enteric dysfunction (EED) and on linear growth during childhood. Genomic subtypes of EPEC from stool samples collected from 1705 children enrolled in the MAL-ED birth cohort were detected by TaqMan Array Cards. We measured site-specific incidence rate by using Poisson regression models, identified the risk factors and estimated the association of genomic subtypes of EPEC with the composite EED score and linear growth at 24 months of age. In general, the highest incidence rate (39%) was found among children having aEPEC infection, which was the greatest in Tanzania (54%). Exclusive breastfeeding and having an improved sanitation facility were found to be protective factors against EPEC infection. In the multivariate models, in overall effect after adjusting for the potential covariates aEPEC showed strong positive associations with the EED scores and tEPEC showed a positive association with poor linear growth at 24 months of age. Our analyses may lay the cornerstone for a prospective epidemiologic investigation for a potential vaccine development aimed at reducing the burden of EPEC infections and combat childhood malnutrition.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35388098 PMCID: PMC8986875 DOI: 10.1038/s41598-022-09730-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
General characteristics of the MAL-ED study children (n = 1715) from Bangladesh, India, Nepal, Pakistan, South Africa, Tanzania, Brazil, and Peru from November 2009 to February 2012.
| Characteristics n (%) | Bangladesh | Brazil | India | Nepal | Peru | Pakistan | South Africa | Tanzania | Overall |
|---|---|---|---|---|---|---|---|---|---|
| Gender (male) | 108 (51.43) | 89 (53.94) | 105 (46.26) | 122 (53.74) | 105 (54.12) | 120 (48.78) | 120 (50.63) | 105 (50.24) | 874 (50.96) |
| Days of exclusive breastfeedingc | 143.2 ± 42.7 | 93.7 ± 57.8 | 105.4 ± 42.9 | 92.5 ± 54.5 | 89.5 ± 61.3 | 19.9 ± 22.7 | 38.6 ± 26.3 | 62.2 ± 35 | 78.6 ± 57.7 |
| Birth weight (Kg)c | 2.8 ± 0.4 | 3.4 ± 0.5 | 2.9 ± 0.4 | 3.0 ± 0.4 | 3.1 ± 0.4 | 2.7 ± 0.4 | 3.2 ± 0.5 | 3.2 ± 0.5 | 3.0 ± 0.5 |
| Weight for age z score at enrollmentc | − 1.3 ± 0.9 | − 0.2 ± 1.0 | − 1.3 ± 1.0 | − 0.9 ± 1.0 | − 0.6 ± 0.9 | − 1.4 ± 1.0 | − 0.4 ± 1.0 | − 0.1 ± 1.1 | − 0.8 ± 1.1 |
| Length for age z score at enrollmentc | − 1.0 ± 1.0 | − 0.8 ± 1.1 | − 1.0 ± 1.1 | − 0.7 ± 1.0 | − 0.9 ± 1.0 | − 1.3 ± 1.1 | − 0.7 ± 1.0 | − 1.0 ± 1.1 | − 0.9 ± 1.1 |
| Length for age z score at 24 monthsc | − 2.0 ± 0.9 | 0.0 ± 1.1 | − 1.9 ± 1.0 | − 1.3 ± 0.9 | − 1.9 ± 0.9 | – | − 1.7 ± 1.1 | − 2.7 ± 1.0 | − 1.7 ± 1.2 |
| Weight for length z score at 24 monthsc | − 0.8 ± 0.9 | 0.5 ± 1.4 | − 0.9 ± 0.9 | − 0.3 ± 0.9 | 0.3 ± 0.9 | – | 0.5 ± 1.0 | 0.1 ± 1.0 | − 0.1 ± 1.1 |
| Maternal age (months)c | 25 ± 5 | 25.4 ± 5.6 | 23.9 ± 4.2 | 26.6 ± 3.7 | 24.8 ± 6.3 | 28.1 ± 5.9 | 27 ± 7.2 | 29.1 ± 6.5 | 26.3 ± 5.9 |
| Maternal BMIac | 22.3 ± 3.4 | 25.7 ± 4.4 | 22.0 ± 4.0 | 25.1 ± 3.2 | 24.9 ± 3.7 | 21.5 ± 3.8 | 27 ± 5.5 | 22.9 ± 3.2 | 23.9 ± 4.4 |
| Maternal education level (< 6y) | 133 (63.3) | 22 (13.3) | 80 (35.2) | 59 (26) | 44 (22.7) | 202 (82.1) | 5 (2.1) | 75 (35.9) | 620 (36.2) |
| Mother has < 3 living children | 160 (76.2) | 113 (68.5) | 157 (69.8) | 199 (87.7) | 111 (57.2) | 105 (42.7) | 141 (59.5) | 58 (27.8) | 1044 (61) |
| Ownership of cattle | 1 (0.5) | 0 | 5 (2.2) | 3 (1.3) | 0 | 146 (59.4) | 33 (13.9) | 157 (75.1) | 345 (20.1) |
| Ownership of chicken | 3 (1.4) | 1 (0.6) | 14 (6.2) | 73 (32.2) | 75 (38.7) | 144 (62.3) | 87 (37.2) | 204 (97.6) | 601 (35.4) |
| Routine treatment of drinking water | 130 (61.9) | 10 (6.1) | 7 (3.1) | 98 (43.2) | 32 (16.5) | 0 | 12 (5.1) | 12 (5.7) | 301 (17.6) |
| Improved drinking water source | 210 (100) | 165 (100) | 227 (100) | 227 (100) | 184 (94.9) | 246 (100) | 196 (82.7) | 89 (42.6) | 1544 (90.0) |
| Improved floor | 204 (97.1) | 165 (100) | 222 (97.8) | 109 (48) | 69 (35.6) | 81 (32.9) | 231 (97.5) | 13 (6.2) | 1094 (63.8) |
| Improved sanitary latrine | 210 (100) | 165 (100) | 121 (53.3) | 227 (100) | 66 (34) | 197 (80.1) | 232 (97.9) | 19 (9.1) | 1237 (72.1) |
| Monthly income < 150 USD | 69 (32.9) | 161 (97.6) | 19 (8.4) | 106 (46.7) | 58 (29.9) | 115 (46.8) | 179 (75.5) | 0 | 707 (41.2) |
| < 2 people live in per room | 8 (3.8) | 141 (85.5) | 46 (20.3) | 126 (55.5) | 122 (62.9) | 27 (10.9) | 201 (84.8) | 95 (45.5) | 766 (44.7) |
| Average serum zinc level (mmol/l)db | 11.3 (10.6, 12.1) | 14 (13, 14.9) | 9.1 (8.6, 9.6) | 11.2 (10.4, 12.2) | 14.8 (13.1, 17.9) | 8.9 (7.7, 10) | 22.9 (14.3, 32.9) | 11.1 (9.9, 12.3) | 11.3 (9.6, 13.7) |
| Average AGP (mg/dL)bd | 84.3 (71.5,105.3) | 95.7 (81, 117) | 97 (83, 110) | 117.7 (102.7, 139) | 115 (98, 130.3) | 93 (77.5, 111.8) | 126 (107.3, 153, 7) | 114.3 (97.7, 138.7) | 106.3 (87, 127) |
aBMI: body mass index.
bAverage of 7, 15 and 24-months serum zinc and plasma AGP (alpha-1-acid glycoprotein) level.
cMean ± Standard deviation.
dMedian (IQR).
Figure 1The incidence rate of infection with the two genomic subtypes of EPEC (tEPEC and aEPEC) across each of the eight study sites (Bangladesh, India, Nepal, Pakistan, South Africa, Tanzania, Brazil, and Peru) from November 2009 to February 2012.
Factors associated with infections by the two genomic subtypes of EPEC across each of the eight study sites (Bangladesh, India, Nepal, Pakistan, South Africa, Tanzania, Brazil, and Peru) from November 2009 to February 2012.
| Factors | tEPEC | aEPEC | ||
|---|---|---|---|---|
| IRR (95% CI) | IRR (95%CI) | |||
| Male | 1.06 (0.99, 1.13) | 0.054 | 1.00 (0.96, 1.03) | 1.00 |
| Exclusive BF (months) | 1.00 (0.99, 1.00) | 0.901 | 0.99 (0.99, 1.00) | < 0.001 |
| Yes | 0.90 (0.80, 1.02) | 0.096 | 0.94 (0.88, 1.01) | 0.086 |
| Yes | 1.02 (0.93, 1.13) | 0.647 | 1.03 (0.98, 1.08) | 0.247 |
| WAZ | 0.99 (0.96, 1.03) | 0.706 | 1.01 (0.99, 1.03) | 0.313 |
| Yes | 0.93 (0.84, 1.03) | 0.175 | 0.99 (0.94, 1.05) | 0.706 |
| Yes | 0.98 (0.86, 1.11) | 0.699 | 1.00 (0.93, 1.07) | 0.943 |
| Yes | 0.96 (0.87, 1.06) | 0.418 | 1.00 (0.95, 1.05) | 0.972 |
| Yes | 0.90 (0.81, 0.99) | 0.026 | 0.98 (0.93, 1.04) | 0.459 |
| Maternal Age | 0.99 (0.99, 1.00) | 0.059 | 1.00 (0.99, 1.00) | 0.295 |
| Yes | 0.93 (0.86, 1.01) | 0.103 | 0.96 (0.92, 1.01) | 0.119 |
| Yes | 0.99 (0.91, 1.07) | 0.75 | 0.98 (0.94, 1.02) | 0.356 |
| Yes | 1.05 (0.96, 1.14) | 0.287 | 1.00 (0.95, 1.05) | 0.998 |
| Maternal education (years) | 0.99 (0.98, 1.00) | 0.054 | 1.00 (0.99, 1.00) | 0.162 |
| Brazil | 0.17 (0.14, 0.22) | < 0.001 | 0.71 (0.65, 0.79) | < 0.001 |
| India | 0.76 (0.67, 0.87) | < 0.001 | 0.99 (0.92, 1.07) | 0.839 |
| Nepal | 0.34 (0.29, 0.40) | < 0.001 | 0.87 (0.81, 0.94) | 0.001 |
| Peru | 0.62 (0.53, 0.73) | < 0.001 | 0.88 (0.81, 0.97) | 0.010 |
| Pakistan | 0.44 (0.37, 0.53) | < 0.001 | 0.48 (0.43, 0.53) | < 0.001 |
| South Africa | 0.23 (0.19, 0.28) | < 0.001 | 0.60 (0.54, 0.66) | < 0.001 |
| Tanzania | 0.82 (0.66, 1.02) | 0.070 | 1.13 (1.00, 1.27) | 0.057 |
Model: Poisson regression; IRR: Incidence rate ratio; aWAZ: Weight-for-age z score.
Dependent variable: Number of infections during follow up (1–24 m).
Offset: Log of the total number of follow up; alpha (α): dispersion parameter.
Adjusted for the site and all variables included in the multivariable model.
Genomic subtypes of EPEC and burden on child growth at 24 months across each of the study sites (except Pakistan) from November 2009 to February 2012.
| Site | Length-for-age z score | |||
|---|---|---|---|---|
| tEPEC | aEPEC | |||
| Coef. (95% CI) | Coef. (95% CI) | |||
| Bangladesh | 0.39 (− 0.82, 1.61) | 0.522 | 0.02 (− 0.91, 0.94) | 0.973 |
| Brazil | − 1.32 (− 4.74, 2.10) | 0.447 | − 0.32 (− 1.61, 0.98) | 0.630 |
| India | − 0.66 (− 2.09, 0.78) | 0.368 | − | |
| Nepal | − | 0.47 (− 0.42, 1.36) | 0.304 | |
| Peru | − 0.50 (− 2.10, 1.09) | 0.535 | 0.41 (− 0.61, 1.42) | 0.431 |
| South Africa | − 2.79 (− 6.05, 0.48) | 0.094 | − 0.60 (− 1.78, 0.58) | 0.320 |
| Tanzania | − 0.81 (− 3.02, 1.41) | 0.471 | − 0.55 (− 2.39, 1.29) | 0.555 |
| Overall | − | − 0.29 (− 0.69, 0.11) | 0.151 | |
Adjusted in the linear regression model for sex, birth weight, exclusive breastfeeding, WAMI Index (water/sanitation, assets, maternal education, and income); enrollment length-for-age z score; maternal BMI; poultry and cattle in house, a mother has less than 3 living children, average serum zinc level, average AGP (alpha-1-acid glycoprotein) level, presence of co-pathogens (Campylobacter, LT-ETEC, ST-ETEC, Shigella/EIEC, and Giardia) and site for overall estimate.
Coef. Coefficient, CI confidence interval.
Association between the genomic subtypes of EPEC and enteric inflammation (EED score: stool Myeloperoxidase, Neopterin, and Alpha-1-Antitrypsin).
| Site | EED score | |||
|---|---|---|---|---|
| tEPEC | aEPEC | |||
| Coef. (95% CI) | Coef. (95% CI) | |||
| Bangladesh | − 0.09 (− 0.35, 0.17) | 0.506 | 0.10 (− 0.11, 0.31) | 0.338 |
| Brazil | − 0.20 (− 0.93, 0.54) | 0.601 | 0.21 (− 0.08, 0.51) | 0.160 |
| India | 0.04 (− 0.20, 0.28) | 0.729 | 0.19 (0.01, 0.37) | 0.043 |
| Nepal | 0.11 (− 0.25, 0.47) | 0.552 | 0.31 (0.11, 0.50) | 0.002 |
| Peru | 0.27 (− 0.08, 0.63) | 0.134 | 0.23 (− 0.02, 0.48) | 0.073 |
| Pakistan | − 0.03 (− 0.33, 0.27) | 0.848 | 0.001 (− 0.22, 0.22) | 0.975 |
| South Africa | 0.31 (− 0.27, 0.89) | 0.290 | 0.02 (− 0.23, 0.28) | 0.860 |
| Tanzania | 0.19 (− 0.09, 0.47) | 0.187 | 0.20 (− 0.02, 0.43) | 0.081 |
| Overall | 0.05 (− 0.07, 0.16) | 0.427 | 0.15 (0.07, 0.23) | < 0.001 |
The dependent variable was log (MPO, NEO, and ALA); Independent variables: the presence of virulence-related genes associated with EPEC at each month.
Adjusted in GEE model for sex, age, WAMI Index (water/sanitation, assets, maternal education, and income); enrollment length-for-age z score; maternal BMI; the number of children, poultry/cattle in house, seasonality, serum zinc level, AGP (alpha-1-acid glycoprotein), presence of co-pathogens (Campylobacter, LT-ETEC, ST-ETEC, Shigella, and Giardia), site for the overall estimate, and age as the time variable. EED score (AAT alpha-1-anti-trypsin, MPO myeloperoxidase, NEO neopterin).
Coef. Coefficient, CI confidence interval.